Advanced in silico characterization of nanomaterials for nanoparticle toxicology
Ian Rouse, David Power, Erik G. Brandt, Matthew Schneemilch,, Konstantinos Kotsis, Nick Quirke, Alexander P. Lyubartsev, Vladimir Lobaskin

TL;DR
This paper presents an advanced computational approach for characterizing nanomaterials, specifically titanium dioxide nanoparticles, to predict their toxicity in silico, addressing safety testing limitations.
Contribution
It introduces a multiscale computational method for nanomaterial characterization based solely on chemical and structural data to aid toxicity prediction.
Findings
Successful application to titanium dioxide nanoparticles
Potential to predict biological activity from physicochemical properties
Supports nanoinformatics as a safe alternative to experimental testing
Abstract
Nanomaterials possess a wide range of potential applications due to their novel properties compared to bulk matter, but these same properties may represent an unknown risk to health. Experimental safety testing cannot keep pace with the rate at which new nanoparticles are developed and, being lengthy and expensive, often hinders the development of technology. An economic alternative to in vitro and in vivo testing is offered by nanoinformatics, potentially enabling the quantitative relation of the nanomaterial properties to their crucial biological activities. Recent research efforts have demonstrated that such activities can be successfully predicted from the physicochemical characteristics of nanoparticles, especially those related to the bionano interface, by means of statistical models. In this work, as a step towards in silico prediction of toxicity of nanomaterials, an advanced…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods
